Ceren SARİ, Ceren SUMER, Figen CELEP EYUPOGLU

4220

Caffeic acid phenethyl ester induces apoptosis in colorectal cancer cells via inhibition of survivin

Colorectal cancer is one of the most common types of cancer. Drug resistance and drug-induced damage of healthy tissues are major obstacles in cancer treatment. Therefore, to develop efficient anticancer therapy, it is necessary to find compounds that affect tumor cells, but do not exhibit toxicity to healthy cells. Caffeic acid phenethyl ester (CAPE) has been demonstrated to have anticancer properties in many types of cancer. In this study, the cytotoxic and apoptotic effects of CAPE on the RKO colorectal cancer cell line and CCD 841-CoN normal colorectal cell line was investigated. In addition, changes in the survivin expression were determined. According to the results, CAPE decreased cell viability in the RKO cell line in a dose-dependent manner. Likewise, CAPE induced apoptotic cell death in approximately 40% of the RKO cells. Furthermore, CAPE treatment increased the Serine 15 (Ser15) and Serine 46 (Ser46) phosphorylation of p53, while decreased the survivin expression. The results suggested that CAPE induced apoptosis by regulating p53 phosphorylation, leading to inhibition of the survivin expression. In accordance with the results, it is suggested that CAPE might be evaluated as an alternative drug in cancer therapy and further investigation is needed within this scope.
Keywords:

Anticarcinogenic agents apoptosis, caffeic acids, colorectal cancer,

PDF

___

  • Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968
  • Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016
  • Chen MF, 2004, J RADIAT RES, V45, P253, DOI 10.1269/jrr.45.253
  • Chen X, 2016, J CANCER, V7, P314, DOI 10.7150/jca.13332
  • Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374
  • Chu XY, 2012, J SURG ONCOL, V105, P520, DOI 10.1002/jso.22134
  • dos Santos JS, 2013, J BURN CARE RES, V34, P682, DOI 10.1097/BCR.0b013e3182839b1c
  • Dziedzic A, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6793456
  • Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996
  • Fulda S, 2010, PLANTA MED, V76, P1075, DOI 10.1055/s-0030-1249961
  • Gherman C, 2016, MOL CELL BIOCHEM, V413, P189, DOI 10.1007/s11010-015-2652-3
  • Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x
  • He YJ, 2014, WORLD J GASTROENTERO, V20, P11840, DOI 10.3748/wjg.v20.i33.11840
  • Kabala-Dzik A, 2018, INTEGR CANCER THER, V17, P1247, DOI 10.1177/1534735418801521
  • Kawasaki H, 1998, CANCER RES, V58, P5071
  • Koehler BC, 2014, WORLD J GASTROENTERO, V20, P1923, DOI 10.3748/wjg.v20.i8.1923
  • Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65
  • Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801
  • Kurihara A, 2007, GENES CELLS, V12, P853, DOI 10.1111/j.1365-2443.2007.01097.x
  • Li DY, 2018, BIOMED REP, V8, P399, DOI 10.3892/br.2018.1077
  • Lin HP, 2015, ONCOTARGET, V6, P6684, DOI 10.18632/oncotarget.3246
  • Lin HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031286
  • Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501
  • Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353
  • Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746
  • Murtaza G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/145342
  • Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090
  • Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8
  • Peery RC, 2017, DRUG DISCOV TODAY, V22, P1466, DOI 10.1016/j.drudis.2017.05.009
  • Shen CX, 2009, ANTICANCER RES, V29, P1423
  • Sulaiman GM, 2014, INT J FOOD SCI NUTR, V65, P101, DOI 10.3109/09637486.2013.832174
  • Temraz S, 2013, INT J MOL SCI, V14, P17279, DOI 10.3390/ijms140917279
  • Urruticoechea A, 2010, CURR PHARM DESIGN, V16, P3, DOI 10.2174/138161210789941847
  • Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Sumeyye AYDOGAN TURKOGLU, Gizem DAYİ, Feray KOCKAR

Effects of moderate high temperature and UV-B on accumulation of withanolides and relative expression of the squalene synthase gene in Physalis peruviana

Murat TELLİ, Fatma PEHLİVAN KARAKAŞ, Ercan Selçuk ÜNLÜ, Günce ŞAHİN

Ceren SARİ, Ceren SUMER, Figen CELEP EYUPOGLU

Adjuvant potency of Astragaloside VII embedded cholesterol nanoparticles for H3N2 influenza vaccine

Rükan GENÇ, Fethiye ÇÖVEN, Nilgün YAKUBOĞULLARI, Erdal BEDİR, Ayşe NALBANTSOY

Rukan GENC, Nilgun YAKUBOGULLARİ, Ayse NALBANTSOY, Fethiye COVEN, Erdal BEDİR

Gunce SAHİN, Murat TELLİ, Ercan Selçuk ÜNLÜ, Fatma PEHLİVAN KARAKAŞ

Pakize Neslihan TASLİ, Gul Merve YALCİN ULKER, Alev CUMBUL, Unal USLU, Sahin YİLMAZ, Batuhan Turhan BOZKURT, Fikrettin SAHİN

Regulation of E2F1 activity via PKA-mediated phosphorylations

Mustafa Gökhan ERTOSUN, Gamze TANRIÖVER, Sayra DİLMAÇ, Sadi KÖKSOY, Osman Nidai ÖZEŞ, Fatma Zehra HAPİL

Upregulation of PSMD4 gene by hypoxia in prostate cancer cells

Feray KÖÇKAR, Sümeyye AYDOĞAN TÜRKOĞLU, Gizem DAYI

Fatma PEHLİVAN KARAKAS, Hamit COSKUN, Hayriye SOYTURK, Bihter Gokce BOZAT